Hepatic impairment, Healthy subjects research hub

A study to assess the safety, tolerability and pharmacokinetics of tideglusib in subjects with hepatic impairment compared to healthy subjects.

This study looks at a new medicine called tideglusib. We want to see how safe it is and how the body handles it in people with liver problems compared to healthy people. This helps us understand if the medicine works differently depending on liver health.